Kaiser EA

No ORCID on file · 1 paper in corpus
2026
Annual review of medicine ·doi:10.1146/annurev-med-050224-111631

Therapeutic targeting of the neuropeptide calcitonin gene-related peptide (CGRP) is a bench-to-bedside success story that has established migraine as a treatable neurological disorder. There are now eight monoclonal antibodies and small-mol…